The Use of Rifampicin-Miconazole-Impregnated Catheters Reduces the Incidence of Femoral and Jugular Catheter-Related Bacteremia.

Link to article at PubMed

Related Articles

The Use of Rifampicin-Miconazole-Impregnated Catheters Reduces the Incidence of Femoral and Jugular Catheter-Related Bacteremia.

Clin Infect Dis. 2008 Sep 22;

Authors: Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A

Background. @nbsp; The guidelines of the Centers for Disease Control and Prevention do not recommend the use of an antimicrobial- or antiseptic-impregnated catheter for short-term use. In previous studies, we have found a higher incidence of central venous catheter-related bacteremia among patients with femoral and central jugular accesses than among patients with other venous accesses. Objective. @nbsp; The objective of our study was to determine the incidence of central venous catheter-related bacteremia associated with rifampicin-miconazole-impregnated catheters and standard catheters in patients with femoral and central jugular venous accesses. Methods. @nbsp; This was a cohort study, conducted in the 24-bed polyvalent medical-surgical intensive care unit of a university hospital. We included patients who were admitted to the intensive care unit from 1 June 2006 through 30 September 2007 and who underwent femoral or central jugular venous catheterization. Results. @nbsp; We inserted 184 femoral (73 rifampicin-miconazole-impregnated catheters and 111 standard catheters) and 241 central jugular venous catheters (114 rifampicin-miconazole-impregnated catheters and 127 standard catheters). We found a lower rate of central venous catheter-related bacteremia associated with rifampicin-miconazole-impregnated catheters than with standard catheters among patients with femoral access (0 vs. 8.62 cases per 1000 catheter-days; odds ratio, 0.13; 95% confidence interval, 0.00-0.86; [Formula: see text]) and among patients with central internal jugular access (0 vs. 4.93 cases per 1000 catheter-days; odds ratio, 0.13; 95% confidence interval, 0.00-0.93; [Formula: see text]). Conclusions. @nbsp; Rifampicin-minonazole-impregnated catheters are associated with a statistically significant reduction in the incidence of catheter-related bacteremia in patients with short-term catheter use at the central jugular and femoral sites.

PMID: 18808356 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *